Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren Scarpetti

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Seminars in Oncology Nursing|August 21, 2022
Cancer; Pathophysiology and Stress Modulation (Cancer, Therapeutic Interventions)Lauren Scarpetti, Matthew Guarino, Jennifer Baima
Clinical Lymphoma, Myeloma & Leukemia|July 26, 2025
Moving Towards the Delivery of Outpatient T-Cell Engaging Therapy for the Management of Multiple MyelomaMaya Rosenberg, Lauren Scarpetti, Gareth J Morgan, et al.
American Journal of Surgery|August 15, 2024
Utility of ligamentum teres hepatis flap reinforcement to prevent postoperative pancreatic fistulas in robotic distal pancreatectomyLauren Scarpetti, Ricardo J Bello, Sebastian K Chung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 25, 2020
Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancerStephanie Alimena, Lauren Scarpetti, Erica L Blouch, et al.
The Oncologist|February 11, 2023
Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53Lauren Scarpetti, Chetan C Oturkar, Dejan Juric, et al.
NPJ Breast Cancer|January 8, 2025
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)Laura M Spring, Lauren Scarpetti, Arielle J Medford, et al.
The Lancet. Oncology|April 30, 2026
Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trialSeth A Wander, Maxwell R Lloyd, Jennifer C Keenan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Seminars in Oncology Nursing|August 21, 2022
Cancer; Pathophysiology and Stress Modulation (Cancer, Therapeutic Interventions)Lauren Scarpetti, Matthew Guarino, Jennifer Baima
Clinical Lymphoma, Myeloma & Leukemia|July 26, 2025
Moving Towards the Delivery of Outpatient T-Cell Engaging Therapy for the Management of Multiple MyelomaMaya Rosenberg, Lauren Scarpetti, Gareth J Morgan, et al.
American Journal of Surgery|August 15, 2024
Utility of ligamentum teres hepatis flap reinforcement to prevent postoperative pancreatic fistulas in robotic distal pancreatectomyLauren Scarpetti, Ricardo J Bello, Sebastian K Chung, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 25, 2020
Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancerStephanie Alimena, Lauren Scarpetti, Erica L Blouch, et al.
The Oncologist|February 11, 2023
Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53Lauren Scarpetti, Chetan C Oturkar, Dejan Juric, et al.
NPJ Breast Cancer|January 8, 2025
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2- breast cancer (LEADER)Laura M Spring, Lauren Scarpetti, Arielle J Medford, et al.
The Lancet. Oncology|April 30, 2026
Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trialSeth A Wander, Maxwell R Lloyd, Jennifer C Keenan, et al.
Pageof 1